The Pros and Cons of Using Ionic Liquids in the Pharmaceutical Industry

Author(s):  
Richard Freer ◽  
Alan Curzons
Antibiotics ◽  
2020 ◽  
Vol 9 (9) ◽  
pp. 578
Author(s):  
Cristina Prudêncio ◽  
Mónica Vieira ◽  
Seppe Van der Auweraer ◽  
Ricardo Ferraz

Antibiotics are considered one of the great “miracles” of the 20th century. Now in the 21st century in the post-antibiotic era, the miracle is turning into a nightmare, due to the growing problem of the resistance of microorganisms to classic antimicrobials and the non-investment by the pharmaceutical industry in new antimicrobial agents. Unfortunately, the current COVID-19 pandemic has demonstrated the global risks associated with uncontrolled infections and the various forms of impact that such a pandemic may have on the economy and on social habits besides the associated morbidity and mortality. Therefore, there is an urgent need to recycle classic antibiotics, as is the case in the use of ionic liquids (ILs) based on antibiotics. Thus, the aim of the present review is to summarize the data on ILs, mainly those with antimicrobial action and especially against resistant strains. The main conclusions of this article are that ILs are flexible due to their ability to modulate cations and anions as a salt, making it possible to combine the properties of both and multiplying the activity of separate cations and anions. Also, these compounds have low cost methods of production, which makes it highly attractive to explore them, especially as antimicrobial agents and against resistant strains. ILs may further be combined with other therapeutic strategies, such as phage or lysine therapy, enhancing the therapeutic arsenal needed to fight this worldwide problem of antibacterial resistance. Thus, the use of ILs as antibiotics by themselves or together with phage therapy and lysine therapy are promising alternatives against pathogenic microorganisms, and may have the possibility to be used in new ways in order to restrain uncontrolled infections.


2016 ◽  
Vol 12 ◽  
pp. 1911-1924 ◽  
Author(s):  
Maurizio Selva ◽  
Alvise Perosa ◽  
Sandro Guidi ◽  
Lisa Cattelan

The use of ionic liquids (ILs) as organocatalysts is reviewed for transesterification reactions, specifically for the conversion of nontoxic compounds such as dialkyl carbonates to both linear mono-transesterification products or alkylene carbonates. An introductory survey compares pros and cons of classic catalysts based on both acidic and basic systems, to ionic liquids. Then, innovative green syntheses of task-specific ILs and their representative applications are introduced to detail the efficiency and highly selective outcome of ILs-catalyzed transesterification reactions. A mechanistic hypothesis is discussed by the concept of cooperative catalysis based on the dual (electrophilic/nucleophilic) activation of reactants.


Author(s):  
Robert Geyer

Direct-to-consumer advertising for prescription drugs (DTCA-PD) is currently banned in the EU, but the pharmaceutical industry (supported by key member states and DG Enterprise) made two major attempts to overturn it in the 2000s at the EU level and failed. What does this failure imply for the debates surrounding this policy area and EU health policy in general? To explore this question, this article will define DTCA-PD, examine its pros and cons, provide a brief overview of EU health policy and present a detailed review of the two recent attempts to overturn the ban. Following this, it will examine the five key elements of EU health policy, evaluate their relevance to the development of the EU's policy towards DTCA-PD and briefly speculate on the future of the ban.


2021 ◽  
pp. 118145
Author(s):  
Wenchang Zhuang ◽  
Kadda Hachem ◽  
Dmitry Bokov ◽  
Mohammad Javed Ansari ◽  
Ali Taghvaie Nakhjiri

Author(s):  
Julia L. Shamshina ◽  
Paula Berton ◽  
Hui Wang ◽  
Xiaosi Zhou ◽  
Gabriela Gurau ◽  
...  

Author(s):  
Regina Kemp ◽  
Kevin Fraser ◽  
Kyoko Fujita ◽  
Douglas MacFarlane ◽  
Gloria Elliott

The stabilization of proteins is a priority for several important fields, most notably the pharmaceutical industry. Protein-based therapeutic drugs have demonstrated significant efficacy in controlling and curing disease. Unlike traditional small molecule-based drug therapies, a major hurdle in the development of protein drugs is the challenge of maintaining the protein in the folded state throughout processing and also during storage at the end point-of-use. When a protein is taken from its native environment, it is often unstable and unfolds. Because the protein’s 3-dimensional structure is responsible for its functional activity, much work has been dedicated to finding excipients that will stabilize proteins outside of their native environment.


2019 ◽  
Vol 21 (21) ◽  
pp. 11464-11475 ◽  
Author(s):  
Fabio Ramondo ◽  
Lorenzo Gontrani ◽  
Marco Campetella

A combination of X-ray diffraction with molecular simulations is used to describe complex ionic liquids, and the pros and cons of different ε and polarisable force fields are discussed.


2007 ◽  
Vol 41 (12) ◽  
pp. 29
Author(s):  
KERRI WACHTER
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document